CIRCULATING LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR ARE ASSOCIATED WITH MILD PULMONARY DYSFUNCTION AFTER CARDIOPULMONARY BYPASS
Hugo Tannus Furtado de Mendonça-Filho(Hospital Pró-Cardíaco), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Bernardo Rangel Tura(Instituto Nacional de Cardiologia), Fernando A. Bozza(D’Or Institute for Research and Education), Rachel N. Gomes(Fundação Oswaldo Cruz), Luís Antonio de Almeida Campos(Hospital Pró-Cardíaco), Renato Vieira Gomes(Hospital Pró-Cardíaco), Edson Nunes(Hospital Pró-Cardíaco)
Cited by 34
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527